Acute hypercytokinaemia represents an imbalance of pro-inflammatory and anti-inflammatory cytokines, and is believed to be responsible for the development of acute respiratory distress syndrome and multiple organ failure in severe cases of avian (H5N1) influenza. Although neuraminidase inhibitors are effective in treating avian influenza, especially if given within 48 h of infection, it is harder to prevent the resultant hypercytokinaemia from developing if the patient does not seek timely medical assistance. Steroids have been used for many decades in a wide variety of inflammatory conditions in which hypercytokinaemia plays a role, such as sepsis and viral infections, including severe acquired respiratory syndromes and avian influenza. However, to date, the results have been mixed. Part of the reason for the discrepancies might be the lack of understanding that low doses are required to prevent mortality in cases of adrenal insufficiency. Adrenal insufficiency, as defined in the sepsis/shock literature, is a plasma cortisol rise of at least 9 μg dl−1 following a 250 μg dose of adrenocorticotropin hormone (ACTH), or reaching a plasma cortisol concentration of >25 μg dl−1 following a 1–2 μg dose of ACTH. In addition, in the case of hypercytokinaemia induced by potent viruses, such as H5N1, systemic inflammation-induced, acquired glucocorticoid resistance is likely to be present. Adrenal insufficiency can be overcome, however, with prolonged (7–10 or more days) supraphysiological steroid treatment at a sufficiently high dose to address the excess activation of NF-κB, but low enough to avoid immune suppression. This is a much lower dose than has been typically used to treat avian influenza patients. Although steroids cannot be used as a monotherapy in the treatment of avian influenza, there might be a potential role for their use as an adjunct treatment to antiviral therapy if appropriate dosages can be determined. In this paper, likely mechanisms of adrenal insufficiency are discussed, drawing from a broad background of literature sources.
AliM.,
AllenH. R.,
VedeckisW. V.,
LangC. H.1991; Depletion of rat liver glucocorticoid receptor hormone-binding and its mRNA in sepsis. Life Sci 48:603–611[CrossRef]
AnnaneD.,
SebilleV.,
TrocheG.,
RaphaelJ. C.,
GajdosG.,
BellisantE.2000; A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038–1045[CrossRef]
AnnaneD.,
BellissantE.,
BollaertP. E.,
BriegelJ.,
KehD.,
KupferY.2004; Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329:480[CrossRef]
BeigelJ. H.,
FarrarJ.,
HanA. M.,
HaydenF. G.,
HyerR.,
de JongM. D.,
LochindaratS.,
TienN. T. K.,
HeinN. T.other authors2005; Avian influenza A (H5N1) infection in humans. N Engl J Med 353:1374–1385[CrossRef]
BernardG.2002; The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock. Crit Care 6:384–386[CrossRef]
ChanM. C. W.,
CheungC. Y.,
ChuiW. H.,
TsaoS. W.,
NichollsJ. M.,
ChanY. O.,
ChanR. W. Y.,
LongH. T.,
PoonL. L. M.other authors2005; Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6:135[CrossRef]
CutoloM.,
SulliA.,
PizzorniC.,
SecchiM. E.,
SoldanoS.,
SerioloB.,
StarubR. H.,
OtsaK.,
MaestroniG. J.2006; Circadian rhythms: glucocorticoids and arthritis. Ann N Y Acad Sci 1069:289–299[CrossRef]
de JongM. D.,
SimmonsC. P.,
ThanhT. T.,
HienV. M.,
SmithG. J. D.,
ChauT. N. B.,
HoangD. M.,
ChauN. V. V.,
KhanhT. H.other authors2006; Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12:1203–1207[CrossRef]
GomersallC. D.,
KargelM. J.,
LapinskyS. E.2004; Pro/con clinical debate: steroids are a key component in the treatment of SARS. Crit Care 8:105–107[CrossRef]
HienT. T.,
LiemN.T.,
DungN. T.,
SanL. T.,
MaiP. P.,
van Vinh ChauN.,
SuuP. T.,
DongV. C.,
MaiL. T. Q.other authors2004; Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 350:1179–1188[CrossRef]
HsiehS. M.,
ChangS. C.2006; Cutting edge: insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol 176:4530–4533[CrossRef]
JaattelaM.,
IlvesmakiV.,
VoutilainenR.,
StenmanU. H.,
SakselaE.1991; Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 128:623–629[CrossRef]
KandunI. N.,
WibisonoH.,
SedyaningsihE. R.,
YusharmenD. P. H.,
HadisoedarsunoW.,
PurbaW.,
SantosoH.,
SeptiawatiC.,
TresnaningsihE.other authors2006; Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 355:2186–2194[CrossRef]
KashJ. C.,
BaslerC. F.,
García-SastreA.,
CarterV.,
BillharzR.,
SwayneD. E.,
PrzygodzkiR. M.,
TaubenbergerJ. K.,
KatzeM. G.,
TumpeyT. M.2004; Global host immune response: pathogenesis and transcriptional profiling of type A influenza expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J Virol 78:9499–9511[CrossRef]
KennedyM. J.,
CarpenterJ. M.,
LozanoR. A.,
CastileR. G.2002; Impaired recovery of hypothalamic–pituitary–adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler. Ann Allergy Asthma Immunol 88:523–526[CrossRef]
KonstantinosA. P.,
SheridanJ. F.2001; Stress and influenza viral infection: modulation of proinflammatory cytokine responses in the lung. Respir Physiol 128:71–77[CrossRef]
LeeD. C. W.,
CheungC. Y.,
LawA. H. Y.,
MokC. K. P.,
PeirisM.,
LauA. S. Y.2005; p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor α expression in response to avian influenza virus H5N1. J Virol 79:10147–10154[CrossRef]
LiY. M.,
WangS. X.,
GaoH. S.,
WangJ. G.,
WeiC. S.,
ChenL. M.,
HuiW. L.,
YuanS. L.,
JiaoZ. S.other authors2004; Factors of avascular necrosis of femoral head and osteoporosis in SARS patient' convalescence. Zhonghua Yi Xue Za Zhi 84:1348–1353 (in Chinese
LiuB.,
MoriI.,
HossianM. J.,
DongL.,
TakedaK.,
KimuraY.2004; Interleukin-18 improves the early defence system against influenza infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85:423–428[CrossRef]
LoutfyM. R.,
BlattL. M.,
SiminovitchK. A.,
WardS.,
WolffB.,
LhoH.,
PhamD. H.,
DeifH.,
LaMereE. A.other authors2003; Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290:3222–3228[CrossRef]
MeduriG. U.,
ChrousosG. P.1998; Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used in the wrong way?. Chest 114:355–360[CrossRef]
MolijnG. J.,
KoperJ. W.,
van UffelenC. J.,
de JongF. H.,
BrinkmannA. O.,
BruiningH. A.,
LambertsS. W.1995; Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol (Oxf 43:197–203[CrossRef]
NgP. C.,
LamC. W.,
LiA. M.,
WongC. K.,
ChengF. W.,
LeungT. F.,
HonE. K.,
ChanI. H.,
LiC. K.other authors2004; Inflammatory cytokine profile in children with severe acute respiratory syndrome. Pediatrics 113:e7–e14[CrossRef]
NgW. F.,
ToK. F.,
LamW. W.,
NgT. K.,
LeeK. C.2006; The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1 - a review. Hum Pathol 37:381–390[CrossRef]
NunoiH.,
MercadoM. R.,
MizukamiT.,
OkajimaK.,
MorishimaT.,
SakataH.,
NakayamaS.,
MoriS.,
HayashiM.other authors2005; Apoptosis under hypercytokinemia is a possible pathogenesis in influenza-associated encephalopathy. Pediatr Int 47:175–179[CrossRef]
OnoguchiK.,
YoneyamaM.,
TakemuraA.,
AkiraS.,
TaniguchiT.,
NamikiH.,
FujitaT.2007; Viral infections activate type I and type III interferon genes through a common mechanism. J Biol Chem 282:7576–7581
OttoliniM.,
BlancoJ.,
PorterD.,
PetersonL.,
CurtisS.,
PrinceG.2003; Combination of anti-inflammatory and antiviral therapy of influenza in a cotton rat model. Pediatr Pulmonol 36:290–294[CrossRef]
OttoliniM. G.,
BlancoJ. C. G.,
EichelbergerM. C.,
PorterD. D.,
PletnevaL.,
RichardsonJ. Y.,
PrinceG. A.2005; The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J Gen Virol 86:2823–2830[CrossRef]
PaluckaA. K.,
BlanckJ. P.,
BennettL.,
PascualV.,
BanchereauJ.2005; Cross-regulation of TNF and IFN- α in autoimmune diseases. Proc Natl Acad Sci U S A 102:3372–3377[CrossRef]
PoutanenS. M.,
LowD. E.,
HenryB.,
FinkelsteinS.,
RoseD.,
GreenK.,
TellierR.,
DrakerR.,
AdachiD.other authors2003; Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348:1995–2005[CrossRef]
PretoriusE.,
WallnerB.,
MarxJ.2006; Cortisol resistance in conditions such as asthma and the involvement of 11- β -HSD-2: a hypothesis. Horm Metab Res 38:368–376[CrossRef]
ReilyM. M.,
PantojaC.,
HuX.,
ChinenovY.,
RogatskyI.2006; The GRIP : IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J 25:108–117[CrossRef]
RioJ.,
NosC.,
MarzoM. E.,
TintoreM.,
MontalbanX.1998; Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-lb in relapsing-remitting MS. Neurology 50:1910–1912[CrossRef]
SamuelsM. H.2000; Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study. J Clin Endocrinol Metab 85:1388–1393
SarenevaT.,
MatikainenS.,
KurimotoM.,
JulkunenI.1998; Influenza A virus-induced IFN- αβ and Il-18 synergistically enhance IFN- γ expression in human T cells. J Immunol 160:6032–6038
SuntharalingamG.,
PerryM. R.,
WardS.,
BrettS. J.,
Castello-CortesA.,
BrunnerM. D.,
PanoskaltsisN.2006; Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355:1018–1028[CrossRef]
ToK. F.,
ChanP. K.,
ChanK. F.,
LeeW. K.,
LamW. Y.,
WongK. F.,
TangN. L.,
TsangD. N.,
SungR. Y.other authors2001; Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 63:242–246[CrossRef]
YuenK. Y.,
ChanP. K. S.,
PeirisM.,
TsangD. N. C.,
QueT. L.,
ShortridgeK. F.,
CheungP. T.,
ToW. K.,
HoE. T. F.other authors1998; Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467–471[CrossRef]
ZhaoZ.,
ZhangF.,
XuM.,
HuangK.,
ZhongW.,
CaiW.,
YinZ.,
HuangS.,
DengZ.other authors2003; Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 52:715–720[CrossRef]